The discontinuation of denosumab is associated with increased bone turnover markers and bone loss, but prior treatment with bisphosphonates did not seem to prevent the development of these complications.
Treatment with zoledronate or teriparatide for a year did not affect intima-media thickness of the carotid arteries in postmenopausal women with osteoporosis.
Elderly men were significantly undertreated for osteoporosis compared with elderly women.
A biomechanical computed tomography program used to screen for osteoporosis appears to be a cost-effective alternative to standard care for adults age ≥65 years.
There is no association between insulin resistance and fracture risk in older adults without diabetes.
Researchers assessed the cost-effectiveness of 2 models of osteoporosis care after upper extremity fragility fracture.
Denosumab was superior to risedronate for increasing spine and hip BMD at 24 months of treatment.
Adolescents with atypical anorexia nervosa have higher bone mass density on average than adolescents with anorexia nervosa, but still experience significant deficits in fat mass index.
Lateral areal bone mineral density can identify microstructural heterogeneities that are independent of age and has advantages over anterior-posterior DXA scanning for fracture risk assessment.
Evaluation and treatment rates in men at risk for osteoporosis are strikingly low.
